• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于预测卵巢癌预后的新型组蛋白乙酰化相关基因特征的开发与验证

Development and Validation of a Novel Histone Acetylation-Related Gene Signature for Predicting the Prognosis of Ovarian Cancer.

作者信息

Dai Qinjin, Ye Ying

机构信息

Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.

Department of Cardiothoracic Surgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.

出版信息

Front Cell Dev Biol. 2022 Feb 18;10:793425. doi: 10.3389/fcell.2022.793425. eCollection 2022.

DOI:10.3389/fcell.2022.793425
PMID:35252174
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8894724/
Abstract

Histone acetylation is one of the most common epigenetic modifications, which plays an important role in tumorigenesis. However, the prognostic role of histone acetylation-regulators in ovarian cancer (OC) remains little known. We compared the expression levels of 40 histone acetylation-related genes between 379 OC samples and 88 normal ovarian tissues and identified 37 differently expressed genes (DEGs). We further explored the prognostic roles of these DEGs, and 8 genes were found to be correlated with overall survival ( < 0.1). In the training stage, an 8 gene-based signature was conducted by the least absolute shrinkage and selector operator (LASSO) Cox regression. Patients in the training cohort were divided into two risk subgroups according to the risk score calculated by the 8-gene signature, and a notable difference of OS was found between the two subgroups ( < 0.001). The 8-gene risk model was then verified to have a well predictive role on OS in the external validation cohort. Combined with the clinical characteristics, the risk score was proved to be an independent risk factor for OS. In conclusion, the histone acetylation-based gene signature has a well predictive effect on the prognosis of OC and can potentially be applied for clinical treatments.

摘要

组蛋白乙酰化是最常见的表观遗传修饰之一,在肿瘤发生中起重要作用。然而,组蛋白乙酰化调节因子在卵巢癌(OC)中的预后作用仍鲜为人知。我们比较了379个OC样本和88个正常卵巢组织中40个组蛋白乙酰化相关基因的表达水平,鉴定出37个差异表达基因(DEGs)。我们进一步探讨了这些DEGs的预后作用,发现8个基因与总生存期相关(<0.1)。在训练阶段,通过最小绝对收缩和选择算子(LASSO)Cox回归构建了基于8个基因的特征。根据由8基因特征计算出的风险评分,将训练队列中的患者分为两个风险亚组,发现两个亚组之间的总生存期存在显著差异(<0.001)。然后在外部验证队列中验证了8基因风险模型对总生存期具有良好的预测作用。结合临床特征,风险评分被证明是总生存期的独立危险因素。总之,基于组蛋白乙酰化的基因特征对OC的预后具有良好的预测作用,并且有可能应用于临床治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f58c/8894724/254044458c57/fcell-10-793425-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f58c/8894724/b8e9176d4d1f/fcell-10-793425-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f58c/8894724/1a1507e9124e/fcell-10-793425-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f58c/8894724/56ba686dd2f2/fcell-10-793425-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f58c/8894724/17f780fa23b7/fcell-10-793425-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f58c/8894724/df2bf8d7f971/fcell-10-793425-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f58c/8894724/cab446c5858d/fcell-10-793425-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f58c/8894724/5018573e8d43/fcell-10-793425-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f58c/8894724/bcb05a7c250f/fcell-10-793425-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f58c/8894724/254044458c57/fcell-10-793425-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f58c/8894724/b8e9176d4d1f/fcell-10-793425-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f58c/8894724/1a1507e9124e/fcell-10-793425-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f58c/8894724/56ba686dd2f2/fcell-10-793425-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f58c/8894724/17f780fa23b7/fcell-10-793425-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f58c/8894724/df2bf8d7f971/fcell-10-793425-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f58c/8894724/cab446c5858d/fcell-10-793425-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f58c/8894724/5018573e8d43/fcell-10-793425-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f58c/8894724/bcb05a7c250f/fcell-10-793425-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f58c/8894724/254044458c57/fcell-10-793425-g009.jpg

相似文献

1
Development and Validation of a Novel Histone Acetylation-Related Gene Signature for Predicting the Prognosis of Ovarian Cancer.一种用于预测卵巢癌预后的新型组蛋白乙酰化相关基因特征的开发与验证
Front Cell Dev Biol. 2022 Feb 18;10:793425. doi: 10.3389/fcell.2022.793425. eCollection 2022.
2
Construction and validation of a histone acetylation-related lncRNA prognosis signature for ovarian cancer.一种用于卵巢癌的组蛋白乙酰化相关lncRNA预后特征的构建与验证
Front Genet. 2022 Oct 12;13:934246. doi: 10.3389/fgene.2022.934246. eCollection 2022.
3
A novel defined pyroptosis-related gene signature for predicting the prognosis of ovarian cancer.一种用于预测卵巢癌预后的新型定义的焦亡相关基因特征。
Cell Death Discov. 2021 Apr 7;7(1):71. doi: 10.1038/s41420-021-00451-x.
4
Comprehensive analysis of histone methylation modification regulators for predicting prognosis and drug sensitivity in lung adenocarcinoma.用于预测肺腺癌预后和药物敏感性的组蛋白甲基化修饰调节因子的综合分析
Front Cell Dev Biol. 2022 Oct 3;10:991980. doi: 10.3389/fcell.2022.991980. eCollection 2022.
5
Development of a five-gene signature as a novel prognostic marker in ovarian cancer.开发一种五基因标志物作为卵巢癌的新型预后标志物。
Neoplasma. 2019 May 23;66(3):343-349. doi: 10.4149/neo_2018_180705N447. Epub 2018 Dec 12.
6
A Novel Defined Risk Signature of the Ferroptosis-Related Genes for Predicting the Prognosis of Ovarian Cancer.一种用于预测卵巢癌预后的铁死亡相关基因的新型定义风险特征。
Front Mol Biosci. 2021 Apr 1;8:645845. doi: 10.3389/fmolb.2021.645845. eCollection 2021.
7
Identification and Validation of Angiogenesis-Related Gene Expression for Predicting Prognosis in Patients With Ovarian Cancer.用于预测卵巢癌患者预后的血管生成相关基因表达的鉴定与验证
Front Oncol. 2022 Jan 3;11:783666. doi: 10.3389/fonc.2021.783666. eCollection 2021.
8
Identification and verification of a ten-gene signature predicting overall survival for ovarian cancer.鉴定和验证一个十基因标志物,用于预测卵巢癌的总生存期。
Exp Cell Res. 2020 Oct 15;395(2):112235. doi: 10.1016/j.yexcr.2020.112235. Epub 2020 Aug 14.
9
A gene signature driven by abnormally methylated DEGs was developed for TP53 wild-type ovarian cancer samples by integrative omics analysis of DNA methylation and gene expression data.通过对DNA甲基化和基因表达数据进行综合组学分析,为TP53野生型卵巢癌样本开发了一种由异常甲基化的差异表达基因驱动的基因特征。
Ann Transl Med. 2023 Jan 15;11(1):20. doi: 10.21037/atm-22-5764.
10
Establishment, immunological analysis, and drug prediction of a prognostic signature of ovarian cancer related to histone acetylation.与组蛋白乙酰化相关的卵巢癌预后特征的建立、免疫分析及药物预测
Front Pharmacol. 2022 Sep 12;13:947252. doi: 10.3389/fphar.2022.947252. eCollection 2022.

引用本文的文献

1
Environmental Xenobiotics and Epigenetic Modifications: Implications for Human Health and Disease.环境外源性物质与表观遗传修饰:对人类健康和疾病的影响
J Xenobiot. 2025 Jul 13;15(4):118. doi: 10.3390/jox15040118.
2
Signatures of H3K4me3 modification predict cancer immunotherapy response and identify a new immune checkpoint-SLAMF9.H3K4me3修饰特征可预测癌症免疫治疗反应并鉴定出一种新的免疫检查点——信号淋巴细胞激活分子家族成员9(SLAMF9)。
Respir Res. 2025 Jan 15;26(1):17. doi: 10.1186/s12931-024-03093-6.
3
A novel histone acetylation-associated gene signature with prognostic value in Ewing sarcoma.

本文引用的文献

1
Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities.Wnt/β-catenin 信号通路:功能、生物学机制与治疗机会。
Signal Transduct Target Ther. 2022 Jan 3;7(1):3. doi: 10.1038/s41392-021-00762-6.
2
Characterization of Histone Deacetylase Mechanisms in Cancer Development.癌症发展过程中组蛋白去乙酰化酶机制的表征
Front Oncol. 2021 Jul 29;11:700947. doi: 10.3389/fonc.2021.700947. eCollection 2021.
3
NOTUM from Apc-mutant cells biases clonal competition to initiate cancer.APC 突变细胞中的 NOTUM 会促使克隆竞争,从而引发癌症。
一种在尤因肉瘤中具有预后价值的新型组蛋白乙酰化相关基因特征。
Discov Oncol. 2024 Dec 30;15(1):848. doi: 10.1007/s12672-024-01689-4.
4
Regulation of ovarian cancer by protein post-translational modifications.蛋白质翻译后修饰对卵巢癌的调控
Front Oncol. 2024 Nov 29;14:1437953. doi: 10.3389/fonc.2024.1437953. eCollection 2024.
5
Evolving landscape of detection and targeting miRNA/epigenetics for therapeutic strategies in ovarian cancer.卵巢癌治疗策略中用于检测和靶向微小RNA/表观遗传学的不断演变的格局。
Cancer Lett. 2024 Nov 29;611:217357. doi: 10.1016/j.canlet.2024.217357.
6
Explore the expression of mitochondria-related genes to construct prognostic risk model for ovarian cancer and validate it, so as to provide optimized treatment for ovarian cancer.探讨与线粒体相关的基因表达,构建卵巢癌预后风险模型并进行验证,为卵巢癌的优化治疗提供依据。
Front Immunol. 2024 Oct 16;15:1458264. doi: 10.3389/fimmu.2024.1458264. eCollection 2024.
7
RPS6KA1 is a histone acetylation-related oncoprotein in acute myeloid leukemia which is targeted by afzelin.RPS6KA1 是急性髓系白血病中与组蛋白乙酰化相关的癌蛋白,阿夫唑嗪可靶向该蛋白。
BMC Cancer. 2024 Sep 27;24(1):1189. doi: 10.1186/s12885-024-12886-3.
8
Identification of a novel histone acetylation-related long non-coding RNA model combined with qRT-PCR experiments for prognosis and therapy in gastric cancer.一种新型组蛋白乙酰化相关长链非编码RNA模型的鉴定及其联合qRT-PCR实验在胃癌预后和治疗中的应用
Heliyon. 2024 Aug 22;10(17):e36615. doi: 10.1016/j.heliyon.2024.e36615. eCollection 2024 Sep 15.
9
The Roles of Histone Deacetylases in the Regulation of Ovarian Cancer Metastasis.组蛋白去乙酰化酶在调控卵巢癌转移中的作用。
Int J Mol Sci. 2023 Oct 11;24(20):15066. doi: 10.3390/ijms242015066.
10
Post-translational modifications of histones: Mechanisms, biological functions, and therapeutic targets.组蛋白的翻译后修饰:机制、生物学功能及治疗靶点。
MedComm (2020). 2023 May 20;4(3):e292. doi: 10.1002/mco2.292. eCollection 2023 Jun.
Nature. 2021 Jun;594(7863):430-435. doi: 10.1038/s41586-021-03525-z. Epub 2021 Jun 2.
4
Clinical perspectives of BET inhibition in ovarian cancer.BET抑制在卵巢癌中的临床前景
Cell Oncol (Dordr). 2021 Apr;44(2):237-249. doi: 10.1007/s13402-020-00578-6. Epub 2021 Jan 19.
5
FAM83B inhibits ovarian cancer cisplatin resistance through inhibiting Wnt pathway.FAM83B通过抑制Wnt信号通路来抑制卵巢癌顺铂耐药。
Oncogenesis. 2021 Jan 9;10(1):6. doi: 10.1038/s41389-020-00301-y.
6
ROS-Induced SIRT2 Upregulation Contributes to Cisplatin Sensitivity in Ovarian Cancer.活性氧诱导的SIRT2上调有助于卵巢癌对顺铂的敏感性。
Antioxidants (Basel). 2020 Nov 16;9(11):1137. doi: 10.3390/antiox9111137.
7
Treatment of epithelial ovarian cancer.上皮性卵巢癌的治疗。
BMJ. 2020 Nov 9;371:m3773. doi: 10.1136/bmj.m3773.
8
HDAC11: a rising star in epigenetics.HDAC11:表观遗传学的后起之秀。
Biomed Pharmacother. 2020 Nov;131:110607. doi: 10.1016/j.biopha.2020.110607. Epub 2020 Aug 22.
9
Cancer Epigenetics, Tumor Immunity, and Immunotherapy.癌症表观遗传学、肿瘤免疫与免疫治疗。
Trends Cancer. 2020 Jul;6(7):580-592. doi: 10.1016/j.trecan.2020.02.003. Epub 2020 Mar 31.
10
Gene expression and prognosis of sirtuin family members in ovarian cancer.卵巢癌中沉默调节蛋白家族成员的基因表达与预后
Medicine (Baltimore). 2020 Jun 12;99(24):e20685. doi: 10.1097/MD.0000000000020685.